LifeMD, Inc.
$4.54
The Read: LifeMD’s stock historically moves about 25% on average around catalysts, surging nearly 39% after Q4 2025 earnings on strong EBITDA growth and strategic divestment, but falling about 19% post-Q1 2026 due to a sharp EPS miss despite revenue beats.
Price
Overlays
Panel
LFMD
Hover to view data
No Data